EIR Fougera Pharmaceuticals May 2001

Robert Horan FDA$595.00 - Available Now

FDA investigators audited the Fougera Pharmaceuticals - Melville, NY, United States facility and issued inspectional observation (via FDA 483) on 02 May 2001.

Product details

  • Category:
  • Inspection end: 02 May 2001
  • Location: Melville, United States
  • FEI: 2432435
Add To Cart